Advertisement

Acta Diabetologica

, Volume 53, Issue 3, pp 377–392 | Cite as

Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis

  • Jong Shiuan Yeh
  • Shih-Hsien Sung
  • Hui-Mei Huang
  • Huei-Ling Yang
  • Li-Kai You
  • Shao-Yuan Chuang
  • Po-Chieh Huang
  • Pai-Feng Hsu
  • Hao-Min Cheng
  • Chen-Huan Chen
Original Article

Abstract

Aims

Hypoglycemia has been associated with adverse outcomes in patients with diabetes and critical illness. However, such associations in these populations have not been systematically examined.

Methods

We conducted a systematic review and meta-analysis of longitudinal follow-up cohort studies to investigate the associations between hypoglycemia and various adverse outcomes.

Results

After removing duplicates and critically appraising all screened citations, a total of 19 eligible studies were included. As demonstrated by random-effects meta-analysis, hypoglycemia was strongly associated with a higher risk of adverse events (HR 1.90, 95 % CI 1.63–2.20; P < 0.001). Comparable risk ratios were shown in prespecified stratified analyses investigating above association for different study endpoints, in patients with or without critical illness, in patients with and without diabetes (from 1.47 to 3.31; p for interaction or heterogeneity >0.1). Additionally, a dose-dependent relationship between the severity of hypoglycemia and adverse vascular events and mortality (HR for mild hypoglycemia: 1.68, 95 % CI 1.25–2.26; P < 0.001 and HR for severe hypoglycemia: 2.33, 95 % CI 2.07–2.61; P < 0.001; p for trend 0.02) was observed. Suggested by a bias analysis, the above observations were unlikely to have resulted from unmeasured confounding parameters.

Conclusions

This is the first study demonstrating that hypoglycemia was associated with comparable risk ratios in different study populations and various study endpoints, and a trend of a dose-dependent relationship between hypoglycemia severity and adverse events. The findings of this systematic review support the speculation that hypoglycemia is a risk factor for adverse vascular events and mortality.

Keywords

Hypoglycemia Vascular events Mortality Risk factor 

Notes

Acknowledgments

Hao-min Cheng is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Author contributions

Jong Shiuan Yeh: the literature search, data extraction, manuscript drafting, Shih-Hsien Sung: the literature search, data extraction, manuscript drafting, Hui-Mei Huang: the literature search, data extraction, Huei-Ling Yang: the literature search, data extraction, Li-Kai You: data analysis, Shao-Yuan Chuang: data analysis, Po-Chieh Huang: data analysis, Pai-Feng Hsu: the literature search, data extraction, Hao-Min Cheng: the literature search, data extraction, data analysis, manuscript drafting, Chen-Huan Chen: manuscript drafting.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standard

All included studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards.

Statement of human and animal rights

This article is based on the secondary analysis of primary studies published in the literature. Therefore it does not contain any data obtained directly from human or animal subjects performed by any of the authors.

Informed consent

All persons gave their informed consent prior to their inclusion in the studies.

Supplementary material

592_2015_803_MOESM1_ESM.docx (495 kb)
Supplementary material 1 (DOCX 494 kb)

References

  1. 1.
    Zoungas S, Patel A, Chalmers J et al (2010) Severe hypoglycemia and risks of vascular events and death. N Engl J Med 363:1410–1418CrossRefPubMedGoogle Scholar
  2. 2.
    Investigators N-SS, Finfer S, Liu B et al (2012) Hypoglycemia and risk of death in critically ill patients. N Engl J Med 367:1108–1118CrossRefGoogle Scholar
  3. 3.
    Tsujimoto T, Yamamoto-Honda R, Kajio H et al (2015) Prediction of 90-day mortality in patients without diabetes by severe hypoglycemia: blood glucose level as a novel marker of severity of underlying disease. Acta Diabetol 52:307–314CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589CrossRefPubMedGoogle Scholar
  5. 5.
    The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRefGoogle Scholar
  6. 6.
    UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853CrossRefGoogle Scholar
  7. 7.
    Hemmingsen B, Lund SS, Gluud C et al (2011) Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ (Clin Res Ed) 343:d6898CrossRefGoogle Scholar
  8. 8.
    Action to Control Cardiovascular Risk in Diabetes Study G, Gerstein HC, Miller ME et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559CrossRefGoogle Scholar
  9. 9.
    Goyal A, Mehta SR, Diaz R et al (2009) Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation 120:2429–2437CrossRefPubMedGoogle Scholar
  10. 10.
    Kosiborod M, Inzucchi SE, Krumholz HM et al (2008) Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117:1018–1027CrossRefPubMedGoogle Scholar
  11. 11.
    Svensson A, McGuire DK, Abrahamsson P, Dellborg M (2005) Hypoglycemia during hospitalisation—important risk marker of mortality in diabetic patients with acute coronary events. Eur Heart J 26:248CrossRefGoogle Scholar
  12. 12.
    Yakubovich N, Gerstein HC (2011) Serious cardiovascular outcomes in diabetes: the role of hypoglycemia. Circulation 123:342–348CrossRefPubMedGoogle Scholar
  13. 13.
    McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA (2012) Increased mortality of patients with diabetes reporting severe hypoglycemia. Diab Care 35:1897–1901CrossRefGoogle Scholar
  14. 14.
    Goto A, Arah OA, Goto M, Terauchi Y, Noda M (2013) Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ (Clin Res Ed) 347:f4533Google Scholar
  15. 15.
    Van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461CrossRefPubMedGoogle Scholar
  16. 16.
    van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367CrossRefPubMedGoogle Scholar
  17. 17.
    Arabi YM, Tamim HM, Rishu AH (2009) Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality. Crit Care Med 37:2536–2544CrossRefPubMedGoogle Scholar
  18. 18.
    Hilsted J, Bonde-Petersen F, Norgaard MB et al (1984) Haemodynamic changes in insulin-induced hypoglycaemia in normal man. Diabetologia 26:328–332CrossRefPubMedGoogle Scholar
  19. 19.
    Gill GV, Woodward A, Casson IF, Weston PJ (2009) Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes–the ‘dead in bed’ syndrome revisited. Diabetologia 52:42–45CrossRefPubMedGoogle Scholar
  20. 20.
    Pistrosch F, Ganz X, Bornstein S, Birkenfeld A, Henkel E, Hanefeld M (2015) Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditions. Acta Diabetol. doi: 10.1007/s00592-015-0727-y PubMedGoogle Scholar
  21. 21.
    Nordin C (2014) The proarrhythmic effect of hypoglycemia: evidence for increased risk from ischemia and bradycardia. Acta Diabetol 51:5–14CrossRefPubMedGoogle Scholar
  22. 22.
    Wright RJ, Frier BM (2008) Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diab/Metab Res Rev 24:353–363CrossRefGoogle Scholar
  23. 23.
    Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V (2003) Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diab Care 26:1485–1489CrossRefGoogle Scholar
  24. 24.
    Hsu PF, Sung SH, Cheng HM et al (2013) Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study. Diab Care 36:894–900CrossRefGoogle Scholar
  25. 25.
    Krinsley J, Schultz MJ, Spronk PE et al (2011) Mild hypoglycemia is strongly associated with increased intensive care unit length of stay. Ann Intensive Care 1:49CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Boucai L, Southern WN, Zonszein J (2011) Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med 124:1028–1035CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Bonds DE, Miller ME, Bergenstal RM et al (2010) The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ (Clin Res Ed) 340:b4909CrossRefGoogle Scholar
  28. 28.
    Nicolucci A, Pintaudi B, Rossi MC et al (2015) The social burden of hypoglycemia in the elderly. Acta Diabetol 52(4):677–685CrossRefPubMedGoogle Scholar
  29. 29.
    Anderbro T, Gonder-Frederick L, Bolinder J et al (2015) Fear of hypoglycemia: relationship to hypoglycemic risk and psychological factors. Acta Diabetol 52:581–589CrossRefPubMedGoogle Scholar
  30. 30.
    Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283:2008–2012CrossRefPubMedGoogle Scholar
  31. 31.
    Moher D, Liberati A, Tetzlaff J, Altman DG et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269CrossRefPubMedGoogle Scholar
  32. 32.
    Brodovicz KG, Mehta V, Zhang QY et al (2010) Impact of hypoglycemia among hospitalized insulin-treated patients on inpatient mortality, ischemic events, and neurologic complications. Diabetes 59:A8–A9CrossRefGoogle Scholar
  33. 33.
    Grant RL (2014) Converting an odds ratio to a range of plausible relative risks for better communication of research findings. BMJ (Clin Res Ed) 348:f7450Google Scholar
  34. 34.
    Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  35. 35.
    Lash TL, Fox MP, Fink AK (2009) Applying quantitative bias analysis to epidemiologic data. Springer, New YorkCrossRefGoogle Scholar
  36. 36.
    Borenstein M, Hedges L, Higgins J, Rothstein H (2005) Comprehensive meta-analysis version 2. Biostat, EnglewoodGoogle Scholar
  37. 37.
    Wei M, Gibbons LW, Mitchell TL, Kampert JB, Stern MP, Blair SN (2000) Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation 101:2047–2052CrossRefPubMedGoogle Scholar
  38. 38.
    Fisman EZ, Motro M, Tenenbaum A et al (2004) Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up. Eur J Cardiovasc Prev Rehabil 11:135–143CrossRefPubMedGoogle Scholar
  39. 39.
    Svensson AM, McGuire DK, Abrahamsson P, Dellborg M (2005) Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26:1255–1261CrossRefPubMedGoogle Scholar
  40. 40.
    Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139CrossRefPubMedGoogle Scholar
  41. 41.
    Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C (2009) The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care (London, England) 13:R91CrossRefGoogle Scholar
  42. 42.
    Preiser JC, Devos P, Ruiz-Santana S et al (2009) A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 35:1738–1748CrossRefPubMedGoogle Scholar
  43. 43.
    Gamble JM, Eurich DT, Marrie TJ, Majumdar SR (2010) Admission hypoglycemia and increased mortality in patients hospitalized with pneumonia. Am J Med 123(556):e11–e16PubMedGoogle Scholar
  44. 44.
    Mowery NT, Guillamondegui OD, Gunter OL et al (2010) Severe hypoglycemia while on intensive insulin therapy is not an independent predictor of death after trauma. J Trauma 68:342–347CrossRefPubMedGoogle Scholar
  45. 45.
    Ssekitoleko R, Jacob ST, Banura P et al (2011) Hypoglycemia at admission is associated with inhospital mortality in Ugandan patients with severe sepsis. Crit Care Med 39:2271–2276CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Gruden G, Barutta F, Chaturvedi N et al (2012) Severe hypoglycemia and cardiovascular disease incidence in type 1 diabetes: the EURODIAB prospective complications study. Diab Care 35:1598–1604CrossRefGoogle Scholar
  47. 47.
    Majumdar SR, Hemmelgarn BR, Lin M, McBrien K, Manns BJ, Tonelli M (2013) Hypoglycemia associated with hospitalization and adverse events in older people: population-based cohort study. Diab Care 36:3585–3590CrossRefGoogle Scholar
  48. 48.
    Rathmann W, Kostev K, Gruenberger JB, Dworak M, Bader G, Giani G (2013) Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis. Diab Obes Metab 15:55–61CrossRefGoogle Scholar
  49. 49.
    Duckworth WC, Abraira C, Moritz TE et al (2011) The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA diabetes trial. J Diab Complicat 25:355–361CrossRefGoogle Scholar
  50. 50.
    Stampfer MJ, Ridker PM, Dzau VJ (2004) Risk factor criteria. Circulation 109:IV3CrossRefPubMedGoogle Scholar
  51. 51.
    DeFronzo RA, Hendler R, Christensen N (1980) Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration. Diabetes 29:125–131CrossRefPubMedGoogle Scholar
  52. 52.
    Jin WL, Azuma K, Mita T et al (2011) Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta. Diabetologia 54:1921–1929CrossRefPubMedGoogle Scholar
  53. 53.
    Frier BM, Corrall RJ, Davidson NM, Webber RG, Dewar A, French EB (1983) Peripheral blood cell changes in response to acute hypoglycaemia in man. Eur J Clin Invest 13:33–39CrossRefPubMedGoogle Scholar
  54. 54.
    Hutton RA, Mikhailidis D, Dormandy KM, Ginsburg J (1979) Platelet aggregation studies during transient hypoglycaemia: a potential method for evaluating platelet function. J Clin Pathol 32:434–438CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Di Flaviani A, Picconi F, Di Stefano P et al (2011) Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients. Diab Care 34:1605–1609CrossRefGoogle Scholar
  56. 56.
    Picconi F, Di Flaviani A, Malandrucco I, Giordani I, Frontoni S (2012) Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. Nutr Metab Cardiovasc Dis 22:691–696CrossRefPubMedGoogle Scholar
  57. 57.
    Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH (2010) Glucose variability; does it matter? Endocr Rev 31:171–182CrossRefPubMedGoogle Scholar
  58. 58.
    Risk of hypoglycaemia in types (2007) 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50:1140–1147CrossRefGoogle Scholar
  59. 59.
    Riddle MC, Rosenstock J, Gerich J (2003) The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diab Care 26:3080–3086CrossRefGoogle Scholar
  60. 60.
    Kahn SE, Haffner SM, Heise MA et al (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355:2427–2443CrossRefPubMedGoogle Scholar
  61. 61.
    Chico A, Vidal-Rios P, Subira M, Novials A (2003) The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diab Care 26:1153–1157CrossRefGoogle Scholar
  62. 62.
    Weber KK, Lohmann T, Busch K, Donati-Hirsch I, Riel R (2007) High frequency of unrecognized hypoglycaemias in patients with Type 2 diabetes is discovered by continuous glucose monitoring. Exp Clin Endocrinol Diab 115:491–494CrossRefGoogle Scholar
  63. 63.
    Budnitz DS, Lovegrove MC, Shehab N, Richards CL (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365:2002–2012CrossRefPubMedGoogle Scholar
  64. 64.
    Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55:1577–1596CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2015

Authors and Affiliations

  • Jong Shiuan Yeh
    • 1
  • Shih-Hsien Sung
    • 2
    • 6
    • 7
  • Hui-Mei Huang
    • 5
  • Huei-Ling Yang
    • 5
  • Li-Kai You
    • 3
  • Shao-Yuan Chuang
    • 8
  • Po-Chieh Huang
    • 3
  • Pai-Feng Hsu
    • 4
    • 6
    • 7
  • Hao-Min Cheng
    • 3
    • 6
    • 7
  • Chen-Huan Chen
    • 3
    • 6
    • 7
  1. 1.Cardiology Division, Internal Medicine DepartmentTaipei Medical University Wan-Fang HospitalTaipeiTaiwan
  2. 2.Division of Cardiology, Department of Internal MedicineTaipei Veterans General HospitalTaipeiTaiwan
  3. 3.Department of Medical EducationTaipei Veterans General HospitalTaipeiTaiwan, Roc
  4. 4.Healthcare and Management CenterTaipei Veterans General HospitalTaipeiTaiwan
  5. 5.Nursing DepartmentTaipei Veterans General HospitalTaipeiTaiwan
  6. 6.Institute of Public Health and Community Medicine Research CenterNational Yang-Ming UniversityTaipeiTaiwan
  7. 7.Department of MedicineNational Yang-Ming UniversityTaipeiTaiwan
  8. 8.Division of Preventive Medicine and Health ServiceResearch Institute of Population Health Sciences, National Health Research InstitutesMiaoliTaiwan

Personalised recommendations